CME vs CBOE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CME

43.7
AI Score
VS
CME Wins

CBOE

35.6
AI Score

Investment Advisor Scores

CME

Nov 11, 2026
44score
Recommendation
HOLD

CBOE

Nov 11, 2026
36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CME CBOE Winner
Forward P/E 23.5294 28.7356 CME
PEG Ratio 4.1991 3.1218 CBOE
Revenue Growth 13.0% 19.0% CBOE
Earnings Growth 16.1% 43.2% CBOE
Tradestie Score 43.7/100 35.6/100 CME
Profit Margin 63.5% 28.1% CME
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

CME 1M: +13.6% · 3M: +18.2% CBOE 1M: +26.3% · 3M: +26.0%

Current Technical Phase

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 70.6 · Price: $315.87

CBOE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 73

RSI (14): 73.1 · Price: $369.19

Fundamentals Snapshot

Metric CME CBOE
Market Cap — —
Forward P/E 23.9 23.9
Trailing P/E 25.0 26.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.4%
EPS 12.38 14.05
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.